Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Transforming Health Experience and Action through Shifting the Narrative on Obesity in Primary Care Encounters.

Luig T, Keenan L, Campbell-Scherer DL.

Qual Health Res. 2019 Oct 16:1049732319880551. doi: 10.1177/1049732319880551. [Epub ahead of print]

PMID:
31617456
2.

Changing provider behaviour to increase nurse visits for obesity in family practice: the 5As Team randomized controlled trial.

Campbell-Scherer DL, Asselin J, Osunlana AM, Ogunleye AA, Fielding S, Anderson R, Cave A, Johnson JA, Sharma AM.

CMAJ Open. 2019 May 30;7(2):E371-E378. doi: 10.9778/cmajo.20180165. Print 2019 Apr-Jun.

3.

Using Concept Maps to compare obesity knowledge between policy makers and primary care researchers in Canada.

Sturgiss E, Luig T, Campbell-Scherer DL, Lewanczuk R, Green LA.

BMC Res Notes. 2019 Jan 14;12(1):23. doi: 10.1186/s13104-018-4042-x.

4.

Facing obesity: Adapting the collaborative deliberation model to deal with a complex long-term problem.

Luig T, Elwyn G, Anderson R, Campbell-Scherer DL.

Patient Educ Couns. 2019 Feb;102(2):291-300. doi: 10.1016/j.pec.2018.09.021. Epub 2018 Sep 28.

5.

Personalizing obesity assessment and care planning in primary care: patient experience and outcomes in everyday life and health.

Luig T, Anderson R, Sharma AM, Campbell-Scherer DL.

Clin Obes. 2018 Dec;8(6):411-423. doi: 10.1111/cob.12283. Epub 2018 Sep 21.

6.

Understanding Implementation of Complex Interventions in Primary Care Teams.

Luig T, Asselin J, Sharma AM, Campbell-Scherer DL.

J Am Board Fam Med. 2018 May-Jun;31(3):431-444. doi: 10.3122/jabfm.2018.03.170273.

7.

Erratum to: The 5As team patient study: patient perspectives on the role of primary care in obesity management.

Torti J, Luig T, Borowitz M, Johnson JA, Sharma AM, Campbell-Scherer DL.

BMC Fam Pract. 2017 May 4;18(1):58. doi: 10.1186/s12875-017-0631-3. No abstract available.

8.

Impact of the 5As Team study on clinical practice in primary care obesity management: a qualitative study.

Asselin J, Salami E, Osunlana AM, Ogunleye AA, Cave A, Johnson JA, Sharma AM, Campbell-Scherer DL.

CMAJ Open. 2017 Apr 26;5(2):E322-E329. doi: 10.9778/cmajo.20160090.

9.

Redefining obesity: Beyond the numbers.

Sharma AM, Campbell-Scherer DL.

Obesity (Silver Spring). 2017 Apr;25(4):660-661. doi: 10.1002/oby.21801. No abstract available.

10.

The 5As team patient study: patient perspectives on the role of primary care in obesity management.

Torti J, Luig T, Borowitz M, Johnson JA, Sharma AM, Campbell-Scherer DL.

BMC Fam Pract. 2017 Feb 8;18(1):19. doi: 10.1186/s12875-017-0596-2. Erratum in: BMC Fam Pract. 2017 May 4;18(1):58.

11.

Erratum to: The 5As team intervention: bridging the knowledge gap in obesity management among primary care practitioners.

Ogunleye AA, Osunlana A, Asselin J, Cave A, Sharma AM, Campbell-Scherer DL.

BMC Res Notes. 2016 Mar 14;9:164. doi: 10.1186/s13104-016-1930-9. No abstract available.

12.

The 5As team intervention: bridging the knowledge gap in obesity management among primary care practitioners.

Ogunleye A, Osunlana A, Asselin J, Cave A, Sharma AM, Campbell-Scherer DL.

BMC Res Notes. 2015 Dec 22;8:810. doi: 10.1186/s13104-015-1685-8. Erratum in: BMC Res Notes. 2016;9:164.

13.

5As Team obesity intervention in primary care: development and evaluation of shared decision-making weight management tools.

Osunlana AM, Asselin J, Anderson R, Ogunleye AA, Cave A, Sharma AM, Campbell-Scherer DL.

Clin Obes. 2015 Aug;5(4):219-25. doi: 10.1111/cob.12105. Epub 2015 Jun 30.

14.

Implementation and evaluation of the 5As framework of obesity management in primary care: design of the 5As Team (5AsT) randomized control trial.

Campbell-Scherer DL, Asselin J, Osunlana AM, Fielding S, Anderson R, Rueda-Clausen CF, Johnson JA, Ogunleye AA, Cave A, Manca D, Sharma AM.

Implement Sci. 2014 Jun 19;9:78. doi: 10.1186/1748-5908-9-78.

15.

Exenatide may improve maintenance of HbA1c targets, with less hypoglycaemia, but more early adverse effects when compared with low-dose glimepiride.

Campbell-Scherer DL, Johnson JA.

Evid Based Med. 2013 Oct;18(5):e42. doi: 10.1136/eb-2013-101248. Epub 2013 Mar 8. No abstract available.

PMID:
23474698
16.

ACC/AHA guideline update for the management of ST-segment elevation myocardial infarction.

Campbell-Scherer DL, Green LA.

Am Fam Physician. 2009 Jun 15;79(12):1080-6.

17.

Rosuvastatin prevented major cardiovascular events in people with elevated C-reactive protein.

Campbell-Scherer DL, Montori VM.

Evid Based Med. 2009 Apr;14(2):48. doi: 10.1136/ebm.14.2.48. No abstract available.

PMID:
19332604
18.

ACP Journal Club. Rosuvastatin prevented major cardiovascular events in persons with elevated C-reactive protein.

Campbell-Scherer DL, Montori VM.

Ann Intern Med. 2009 Jan 20;150(2):JC1-4. No abstract available.

PMID:
19172709
19.

Hypertension.

Campbell-Scherer DL, Green LA.

Prim Care. 2005 Dec;32(4):1011-25, viii. Review.

PMID:
16326225

Supplemental Content

Loading ...
Support Center